TNM Classification of Malignant Tumours, 7th Edition
By C. Wittekind, M. Gospodarowicz, Leslie Sobin. 2009
10,834 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/bbd683bd9e036c0799855a172117098fc70c504b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Gershenwald
- R. Scolyer
- Japanese Gastric Cancer Association
- Georgina V. Long
- E. Smyth
- K. Hess
- E. Olsen
- V. Sondak
Citations in the corpus
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. (2016, background): “[78] Sobin LH, Gospodarowicz M, Wittekind C, editors.”
- Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. (2020, background): “Reported 5-year survival rates after surgical resection alone are 99% for stage I, 68%e83% for stage II and 45%e65% for stage III disease.(48) In addition, for intermediate stage II, further parameters need consideration to refine the evaluation of risk given the observed variability on prognosis [I”
- The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part‐Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer (2016, background): “In lung cancer, TNM staging has traditionally been based on total tumor size.(33,39,40) Data are accumulating in both the radiologic and pathologic literature to support the concept that invasive size is a better predictor of survival than is total tumor size in lung adenocarcinoma.”
- Statin use and reduced cancer-related mortality. (2012, unknown): “None 4,503 (24) 27,899 (10) 3,604 (24) 10,277 (22)”
- Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. (2015, methodology): “Ki-67 may play a role in predicting prognosis on resected specimens of PCs; however more data are needed to determine the utility in lung NETs [56, 68, 70–72] as opposed to GEP NETs where Ki-67 labeling index is an integral part of the current grading system [1, 73–75].”